SCHEMBL97271

SCHEMBL97271

[CH2]c1ccc(NS(=O)(=O)c2ccc(O)c(C(=O)O)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
MEN1 O00255 6/20 0.62
KMT2A Q03164 6/20 0.62
TSHR P16473 1/20 0.62
POLB P06746 4/20 0.60
KDM4E B2RXH2 3/20 0.60
PTPN5 P54829 1/20 0.59
CASP6 P55212 2/20 0.58
HSD17B10 Q99714 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
GAA P10253 2/20 0.57
MAPT P10636 1/20 0.57
ALOX15 P16050 1/20 0.57
ALOX12 P18054 1/20 0.57
HPGD P15428 2/20 0.54
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504223 0.88 ALDH1A1 (0.65) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL11222668 0.87 ALDH1A1 (0.75) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL13313580 0.86 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL16471445 0.85 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL9997703 0.84 ALDH1A1 (0.67) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL11888673 0.83 MEN1 (0.61) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL1249879 0.82 POLB (0.77) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL16471446 0.82 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL14381983 0.81 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ATSHRPOLB
SCHEMBL17340522 0.81 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB ALDH1A1 2948/4885MEN1 4401/4885KMT2A 1059/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 ALDH1A1 2458/4885MEN1 3912/4885KMT2A 2732/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 ALDH1A1 2458/4885MEN1 3912/4885KMT2A 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.